| 16.05.2022 14:34 | GSK, AZN | AstraZeneca's PTO27 shows positive results in people with asthma | Alliance |
| 16.05.2022 14:25 | GSK | TOP NEWS: GlaxoSmithKline changes name to GSK as demerger continues | Alliance |
| 16.05.2022 14:00 | GSK | Change of name to GSK plc | RNS |
| 16.05.2022 10:14 | CWR, CRE, SDRY | LONDON BROKER RATINGS: Goldman Sachs cuts Aviva but raises Phoenix | Alliance |
| 13.05.2022 17:13 | GSK | Director/PDMR Shareholding | RNS |
| 12.05.2022 16:03 | VMUK, ULVR, TSCO | UK dividends calendar - next 7 days | Alliance |
| 12.05.2022 15:19 | YGEN, BIG, GSK | DIRECTOR DEALINGS: Yourgene CEO and Big Technologies CFO buy shares | Alliance |
| 12.05.2022 08:58 | GSK | Director/PDMR Shareholding | RNS |
| 11.05.2022 17:17 | GSK | Block listing Interim Review | RNS |
| 10.05.2022 10:22 | KGP, SFOR, ABC | LONDON BROKER RATINGS: Deutsche cuts Direct Line; BofA raises Hiscox | Alliance |
| 09.05.2022 14:53 | GSK | Director/PDMR Shareholding | RNS |
| 04.05.2022 17:49 | GSK | Result of AGM | RNS |
| 04.05.2022 10:00 | GSK | Directorate Change | RNS |
| 03.05.2022 16:52 | GSK | Total Voting Rights | RNS |
| 29.04.2022 09:47 | ONT, WISE, HTWS | LONDON BROKER RATINGS: BofA cuts Vodafone; Jefferies cuts Brewin | Alliance |
| 28.04.2022 10:01 | ASC, EZJ, WIZZ | LONDON BROKER RATINGS: BofA lifts Lloyds to 'buy' from 'neutral' | Alliance |
| 28.04.2022 08:23 | SBRY, ULVR, GSK | LONDON BRIEFING: UK consumer firms warn of "unprecedented inflation" | Alliance |
| 27.04.2022 17:12 | LSEG, LOOP, BKG | LONDON MARKET CLOSE: Aveva, housebuilders fail to drag down FTSE 100 | Alliance |
| 27.04.2022 16:03 | ULVR, TRB, TEG | UK shareholder meetings calendar - next 7 days | Alliance |
| 27.04.2022 10:50 | GSK | TOP NEWS SUMMARY: Microsoft shares up, Alphabet down after results | Alliance |
| 27.04.2022 10:06 | GSK | TOP NEWS: Glaxo posts quarterly profit rise; on track demerging Haleon | Alliance |
| 27.04.2022 07:00 | GSK | 1st Quarter Results | RNS |
| 26.04.2022 09:32 | GSK | Director/PDMR Shareholding | RNS |
| 22.04.2022 09:21 | ANTO, BKG, JET | LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley | Alliance |
| 20.04.2022 16:07 | AUY, SMWH, RPS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.04.2022 14:20 | GSK | Drugmaker GlaxoSmithKline faces strike over "derisory" pay offer | Alliance |
| 19.04.2022 08:36 | GSK | GlaxoSmithKline says FDA accepts application for kidney disease drug | Alliance |
| 19.04.2022 07:00 | GSK | Daprodustat application accepted for review by FDA | RNS |
| 14.04.2022 14:23 | GSK | Director/PDMR Shareholding | RNS |
| 14.04.2022 14:15 | GSK | Director/PDMR Shareholding | RNS |
| 14.04.2022 13:29 | GSK | Director/PDMR Shareholding | RNS |
| 14.04.2022 09:53 | PFC, FRP, ATYM | LONDON BROKER RATINGS: BofA raises Rightmove; Berenberg cuts Bunzl | Alliance |
| 13.04.2022 21:59 | TYM, GSP, SXS | TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra | Alliance |
| 13.04.2022 17:11 | GSK | Director/PDMR Shareholding | RNS |
| 13.04.2022 12:20 | BKG, BDEV, PSN | LONDON MARKET MIDDAY: JPMorgan warns on inflation, Ukraine challenges | Alliance |
| 13.04.2022 09:34 | GSK | TOP NEWS: GlaxoSmithKline to buy Sierra Oncology for USD1.9 billion | Alliance |
| 13.04.2022 09:32 | GSK | Director/PDMR Shareholding | RNS |
| 13.04.2022 07:00 | GSK | GSK agrees to acquire Sierra Oncology for $1.9bn | RNS |
| 12.04.2022 17:10 | GSK | Director/PDMR Shareholding | RNS |
| 12.04.2022 16:23 | GSK | Director/PDMR Shareholding | RNS |
| 12.04.2022 16:00 | GSK | Director/PDMR Shareholding | RNS |
| 12.04.2022 15:48 | GSK | Director/PDMR Shareholding | RNS |
| 11.04.2022 09:55 | LTG, BAG, JET | LONDON BROKER RATINGS: Jefferies raises John Wood; Investec cuts Metro | Alliance |
| 05.04.2022 09:45 | BEZ, DARK, MONY | LONDON BROKER RATINGS: Barclays downgrades Lloyds and Virgin Money | Alliance |
| 01.04.2022 16:03 | GSK | Total Voting Rights | RNS |
| 01.04.2022 11:20 | GSK | GSK - segment and product sales reporting changes | RNS |
| 31.03.2022 16:11 | VTY, TCAP, SCT | UK dividends calendar - next 7 days | Alliance |
| 30.03.2022 13:15 | GSK | GSK, CureVac begin development of second generation Covid-19 vaccine | Alliance |
| 30.03.2022 09:57 | GSK | J&J's Cabenuva HIV treatment approved in US for adolescents | Alliance |
| 28.03.2022 13:00 | GSK | Publication of 2022 AGM Notice | RNS |
| 25.03.2022 20:56 | GSK | REPEAT: US FDA revises use for GSK's Covid-19 neutralizing antibody | Alliance |
| 24.03.2022 15:22 | GSK | Director/PDMR Shareholding | RNS |
| 24.03.2022 14:00 | GSK | FDA update: Cabenuva oral lead-in now optional | RNS |
| 23.03.2022 17:03 | GSK | Director/PDMR Shareholding | RNS |
| 23.03.2022 08:55 | GSK | IN BRIEF: GSK Consumer Healthcare prices medium-term debt notes | Alliance |
| 23.03.2022 07:00 | GSK | Issuance of Notes | RNS |
| 22.03.2022 09:45 | ROO, WISE, SFOR | LONDON BROKER RATINGS: Bank of America says buy Experian and Intertek | Alliance |
| 16.03.2022 14:40 | GSK | Director/PDMR Shareholding | RNS |
| 15.03.2022 15:31 | TSCO, EXPN, TCAP | EXECUTIVE CHANGES: Galliford, Mattioli Woods and Telecom Plus chairs | Alliance |
| 15.03.2022 14:45 | GSK | Director/PDMR Shareholding | RNS |
| 15.03.2022 10:00 | GSK | Appointments to Designate Haleon Board | RNS |
| 11.03.2022 14:55 | GSK | Director/PDMR Shareholding | RNS |
| 09.03.2022 13:44 | GSK | Director/PDMR Shareholding | RNS |
| 08.03.2022 18:24 | GSK | GSK Annual Report 2021 on Form 20-F | RNS |
| 04.03.2022 11:03 | GSK | GSK publishes Annual Report 2021 | RNS |
| 01.03.2022 14:30 | GSK | Total Voting Rights | RNS |
| 01.03.2022 13:18 | GSK | Director/PDMR Shareholding | RNS |
| 01.03.2022 10:44 | GSK | GSK submits application to market daprodustat in Europe | Alliance |
| 01.03.2022 09:55 | GSK | Director/PDMR Shareholding | RNS |
| 01.03.2022 07:00 | GSK | Daprodustat application accepted for review by EMA | RNS |
| 28.02.2022 12:10 | ULVR, GSK | TOP NEWS: GSK's Haleon demerger and listing expected in July | Alliance |
| 28.02.2022 11:00 | GSK | GSK introduces Haleon to investors | RNS |
| 28.02.2022 09:51 | JUP, STAN, AGL | LONDON BROKER RATINGS: Stifel prefers AstraZeneca over GlaxoSmithKline | Alliance |
| 28.02.2022 09:34 | GSK | GSK stops RSV phase III vaccine trial in pregnant women after pause | Alliance |
| 28.02.2022 07:00 | GSK | GSK RSV maternal vaccine candidate further update | RNS |
